Anne-Marie Schjerning Olsen

Medicin og biovidenskab

1. Cohort Studies 100%
2. Anti-Inflammatory Agents 98%
3. Myocardial Infarction 97%
4. Atrial Fibrillation 85%
5. Pharmaceutical Preparations 55%
6. Heart Failure 29%
7. Hemorrhage 27%
8. Thyroxine 27%
9. Mortality 27%
10. Confidence Intervals 26%
11. Stroke 24%
12. Clopidogrel 23%
13. Catheter Ablation 20%
14. Thromboembolism 20%
15. Hypothyroidism 19%
16. Drug Therapy 17%
17. Therapeutics 17%
18. Safety 17%
19. Ibuprofen 16%
20. Naproxen 16%
21. Diclofenac 15%
22. Incidence 13%
23. Proprotein Convertase 9 13%
24. Cardiovascular Diseases 12%
25. Hydroxymethylglutaryl-CoA Reductase Inhibitors 12%
26. Duration of Therapy 12%
27. Celecoxib 11%
28. Dabigatran 11%
29. Out-of-Hospital Cardiac Arrest 11%
30. Registries 11%
31. Electric Countershock 11%
32. Thyroid Diseases 11%
33. Comorbidity 10%
34. Denmark 10%
35. Proton Pump Inhibitors 10%
36. Aspirin 10%
37. Peripheral Arterial Disease 9%
38. rofecoxib 9%
39. Syncope 9%
40. Non-Steroidal Anti-Inflammatory Agents 9%
41. Venous Thromboembolism 9%
42. Hyperthyroidism 9%
43. Anticoagulants 9%
44. Warfarin 9%
45. Thyroid Gland 9%
46. International Classification of Diseases 9%
47. Coronary Disease 9%
48. Thrombosis 8%
49. Coronary Angiography 8%
50. Vascular Diseases 8%